The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...

The U.S. Navy will take delivery of new-build battleships, the largest ever built, in an announcement from President Trump in ...

The B-cell depleting therapy is indicated for adults with generalized myasthenia gravis and anti-acetylcholine receptor or ...

EVOLVE104, a First-in-Class CD2 Costimulatory Trispecific T Cell Engager, is First Molecule from EVOLVE Platform to Enter the Clinic ...

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...

Trastuzumab deruxtecan (T-DXd; Enhertu), is a HER2-targeting ADC that is used in ET-treated HER2-low or HER2-ultralow disease and offered meaningful results in DESTINY-Breast04. In a 2025 real-world ...

The centerpiece of the Trump administration’s revamp of the U.S. Navy is the largest surface combatant America will build ...

Key challenges include logistical hurdles, such as the need for specialized training and infrastructure, and financial ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

Chile has passed a bill outlawing the use of mobile phones and other smart devices during classes at elementary and middle schools ...